JW Pharmaceutical Corporation (001065.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 615.62B |
| Enterprise Value | 631.02B |
| P/E Ratio | 6.31 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 0.74 |
| Price/Book Ratio | 1.52 |
| Enterprise/Revenue | 0.78 |
| Enterprise/EBITDA | 5.07 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.14 |
AD
Management Effectiveness
| Return On Assets | 0.15 |
| Return On Equity | 0.27 |
Income Statement
| Revenue | 774.8B |
| Revenue/Share | 34,720.02 |
| Gross Profit | 359.31B |
| EBITDA | 106.62B |
| Net Income | 61.69B |
| Diluted EPS | 2,534.75 |
Balance Sheet
| Total Cash | 59.65B |
| Total Cash/Share | 2,524.54 |
| Total Debt | 71.75B |
| Total Debt/Equity | 0.18 |
| Current Ratio | 1.56 |
| Book Value Per Share | 17,349.57 |
Price History
| 52-Week Change | -21.45 |
| 52-Week High | 30,300 |
| 52-Week Low | 19,710 |
| Moving Average 50 Days | 21,062.6 |
| Moving Average 200 Days | 25,795.65 |
Statistics
| Average Volume | 314 |
| Shares Outstanding | 17.24M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 650 |
| Trailing Annual Dividend Yield | 2.46 |
| Payout Ratio | 0.16 |
| Last Split Factor | 51:50 |
| Last Split Date | December 27, 2023 |
AD
